cbdMD (YCBD) Change in Acquisitions & Divestments (2020)

cbdMD (YCBD) reported Change in Acquisitions & Divestments of $540000.0 for Q4 2020.

cbdMD (YCBD) Change in Acquisitions & Divestments (2020) Analysis & Trends

cbdMD (YCBD) has 1 years of Change in Acquisitions & Divestments data on file, last reported at $540000.0 in Q4 2020.

  • For the quarter ending Q4 2020, Change in Acquisitions & Divestments changed N/A year-over-year to $540000.0; the trailing twelve-month figure through Sep 2022 stood at $540000.0 (changed N/A YoY), and the FY2023 full-year result was $1.0 million, changed N/A from the prior year.
  • Change in Acquisitions & Divestments steadied at $540000.0 in Q4 2020.
  • In the past five years, Change in Acquisitions & Divestments ranged from a high of $540000.0 in Q4 2020 to a low of $540000.0 in Q4 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 88.58 Bn 86.72 Bn -
2 Teva Pharmaceutical Industries 35.90 Bn 32.16 Bn 1.97 Bn
3 Zoetis 32.33 Bn 30.39 Bn 1.62 Bn
4 Takeda Pharmaceutical 27.49 Bn 23.43 Bn 4.39 Bn
5 United Therapeutics 23.14 Bn 20.99 Bn 648.10 Mn
6 RedHill Biopharma 20.53 Bn 20.53 Bn -
7 Viatris 20.29 Bn 18.49 Bn 1.16 Bn
8 Neurocrine Biosciences 17.93 Bn 16.62 Bn 800.70 Mn
9 Elanco Animal Health 12.63 Bn 12.21 Bn 785.00 Mn
10 cbdMD 4.78 Mn 1.39 Mn 3.00 Mn

Historic Data

Download Data
DateValue
Dec 31, 2020 540,000.00
Dec 31, 2020 540,000.00